Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by billy4325on May 15, 2019 5:26pm
75 Views
Post# 29750467

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Peters again

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Peters againI understand your point about excluding R&D and major capex the company would be profitable, however the issue with that is the company is making these expenditures and will continue to do so in the future.  You can't value it just on the base business (unless it's getting liquidated tomorrow or there is a massive management change where they decide to drop everything else - it's not going to happen).  So the value of the company cannot be based on it alone and really depends on whether these new initiatives make significant revenue to offset the additional expenses.  

EbbFlow88 wrote: This argument makes a lot of sense and imagine that it will force many of you to eat your words and exit this stock. They have yet to release anything of real value, but I think there will be a lot in the future. 

Now, if this stock was a company with no revenues, no cash flow, etc. than I would be thinking exactly like you all are. However, I think there is another way to look at it and it should allow you to think in a longer time frame.

Why don't you value the company on current production? I would say if they weren't spending on R+D and other major capex, that they would be a profitable company. They are trading a little over ~2.5x sales. In my opinion, a pretty well priced stock. If more people sell out of frustration, you will be picking up shares of a company that is undervalued on current production with an option of much more. This is not a radical idea that hasn't been discussed here before, but I think it is the most logical way of looking at this story.


Bullboard Posts